Literature DB >> 19402847

A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease.

David E Victorson1, Susan Anton, Alan Hamilton, Susan Yount, David Cella.   

Abstract

OBJECTIVES: Identify important patient-reported concepts of dyspnea and associated activities to develop a dyspnea-specific conceptual model for chronic obstructive pulmonary disease (COPD).
METHODS: Using grounded theory methodologies, we identified key concepts through interviews with 25 COPD patients, review of scientific literature, and input from 22 experts.
RESULTS: Constant comparative thematic analysis of data suggested five primary components of the dyspnea experience: breathlessness, fatigue, activity modification, activity limitation, and emotional response. Two major influences on dyspnea were described as individual exertion and exposure to environmental factors. Patients described a sense of dyspnea-related fear, and reported distress over the impact of dyspnea on health and activity limitation. They emphasized coping via behavioral strategies and medication, and reported that dyspnea caused the stopping or scaling back of activities, taking more time to do things and using adaptive measures or equipment. No existing model of dyspnea in COPD incorporated all of these concepts. We, therefore, developed a dyspnea-specific conceptual model in which the most proximal of concepts (dyspnea symptoms) can impair function and are mediated by personal and environmental factors.
CONCLUSION: Patient and expert input guided the development of a comprehensive dyspnea-specific conceptual model for COPD which will inform the design of future patient-reported outcome measurement tools used to assess dyspnea and related functional limitations.

Entities:  

Mesh:

Year:  2009        PMID: 19402847     DOI: 10.1111/j.1524-4733.2009.00547.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  16 in total

1.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

2.  Identifying key domains of health-related quality of life for patients with chronic obstructive pulmonary disease: interviews with healthcare professionals.

Authors:  Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Caroline B Terwee; Job van der Palen
Journal:  Qual Life Res       Date:  2014-11-16       Impact factor: 4.147

3.  Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Susan E Yount; Jennifer L Beaumont; Shih-Yin Chen; Karen Kaiser; Katy Wortman; David L Van Brunt; Jeffrey Swigris; David Cella
Journal:  Lung       Date:  2016-02-09       Impact factor: 2.584

4.  Development and validation of a computer adaptive test for measuring dyspnea in heart failure.

Authors:  Bernice Ruo; Seung W Choi; David W Baker; Kathleen L Grady; David Cella
Journal:  J Card Fail       Date:  2010-04-08       Impact factor: 5.712

Review 5.  Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature.

Authors:  M Giacomini; D DeJean; D Simeonov; A Smith
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

6.  Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.

Authors:  Monique Hinchcliff; Jennifer L Beaumont; Krishna Thavarajah; John Varga; Anh Chung; Sofia Podlusky; Mary Carns; Rowland W Chang; David Cella
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

7.  Developing a valid patient-reported outcome measure.

Authors:  N E Rothrock; K A Kaiser; D Cella
Journal:  Clin Pharmacol Ther       Date:  2011-10-05       Impact factor: 6.875

8.  A conceptual model of health-related quality of life in sarcoidosis.

Authors:  David E Victorson; David Cella; Heidi Grund; Marc A Judson
Journal:  Qual Life Res       Date:  2013-05-26       Impact factor: 4.147

9.  Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges.

Authors:  Alan L Shields; Yanni Hao; Meaghan Krohe; Andrew Yaworsky; Iyar Mazar; Catherine Foley; Faisal Mehmed; Denise Globe
Journal:  Am Health Drug Benefits       Date:  2016-06

10.  Development of a men's Preference for Testosterone Replacement Therapy (P-TRT) instrument.

Authors:  Sheryl L Szeinbach; Enrique Seoane-Vazquez; Kent H Summers
Journal:  Patient Prefer Adherence       Date:  2012-08-31       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.